1Stability and storage
The temperature and/or humidity control was inadequate.
Inspection Record
Penta Kare Labs, Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Stability and storage
The ongoing stability program for a drug was inadequate.
3Other quality system
The handling of standard operating procedures for good manufacturing practices was inadequate.
4Laboratory and QC controls
The quality control department was not a distinct unit that functioned independently and reported to management independent of any other unit.
About this record
Extracted automatically from the document of the Health Canada inspection on 2025-04-02. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
